Pharmacodynamic effect of imatinib on PDGFRA and PDGFRB phosphorylation
| Patient no. . | Clinical response . | Sample . | Phospho-PDGFRA/PDGFRA . | Phospho-PDGFRB/PDGFRB . |
|---|---|---|---|---|
| 1 | Stable disease with steroid reduction | Pre | .67 | .33 |
| Post | .33 | .4 | ||
| 6 | Major response | Pre | .33 | .2 |
| Post | .33 | 0 | ||
| 11 | Progressive disease | Pre | .67 | .8 |
| Post | .67 | .4 | ||
| 12 | Major response | Pre | .33 | .33 |
| Post | .33 | .33 |
| Patient no. . | Clinical response . | Sample . | Phospho-PDGFRA/PDGFRA . | Phospho-PDGFRB/PDGFRB . |
|---|---|---|---|---|
| 1 | Stable disease with steroid reduction | Pre | .67 | .33 |
| Post | .33 | .4 | ||
| 6 | Major response | Pre | .33 | .2 |
| Post | .33 | 0 | ||
| 11 | Progressive disease | Pre | .67 | .8 |
| Post | .67 | .4 | ||
| 12 | Major response | Pre | .33 | .33 |
| Post | .33 | .33 |